Gadolinium deposition in nephrogenic fibrosing dermopathy - 12/08/11
Doi : 10.1016/j.jaad.2006.10.048
Alan S. Boyd, MD a, b, ⁎ 
, John A. Zic, MD a, Jerrold L. Abraham, MD c
, John A. Zic, MD a, Jerrold L. Abraham, MD c a From the Departments of Medicine (Dermatology)
b Pathology, Vanderbilt University, Nashville
c Department of Pathology, SUNY Upstate Medical University, Syracuse
Correspondence to: Alan S. Boyd, MD, 3900 The Vanderbilt Clinic, Nashville, TN 37232.Nashville, Tennessee, and Syracuse, New York
Abstract |
There is growing recognition of the association between the use of gadolinium-containing radiocontrast agents for magnetic resonance imaging and the serious dermal and systemic disease nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis (NFD/NSF). The pathogenesis of this entity remains unclear; however, our recent observations suggest a likely mechanism for the initial dermal manifestations of this gadolinium toxicity.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. Conflicts of interest: None identified. Reprints not available from the authors. |
© 2007
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 56 - N° 1
P. 27-30 - janvier 2007 Retour au numéro
Article précédent
- Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
- Whitney A. High, Reed A. Ayers, John Chandler, Gary Zito, Shawn E. Cowper
- A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
- Alan Menter, Steven R. Feldman, Gerald D. Weinstein, Kim Papp, Robert Evans, Cynthia Guzzo, Shu Li, Lisa T. Dooley, Cynthia Arnold, Alice B. Gottlieb
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?